Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Heterogeneous expression of CT10, CT45 and GAGE7 antigens and their prognostic significance in human breast carcinoma.

Zhou X, Yang F, Zhang T, Zhuang R, Sun Y, Fang L, Zhang C, Ma Y, Huang G, Ma F, Song C, Jin B.

Jpn J Clin Oncol. 2013 Mar;43(3):243-50. doi: 10.1093/jjco/hys236. Epub 2013 Jan 11.

PMID:
23315387
2.

[Relationship of ezrin protein expression to the carcinogenesis and prognosis of infitrating breast ductal carcinoma].

Ma L, Zhang XH, Xing LX, Li YH, Wang XL, Wang YJ.

Zhonghua Zhong Liu Za Zhi. 2008 Apr;30(4):279-83. Chinese.

PMID:
18788632
3.

Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers.

Chen YT, Ross DS, Chiu R, Zhou XK, Chen YY, Lee P, Hoda SA, Simpson AJ, Old LJ, Caballero O, Neville AM.

PLoS One. 2011 Mar 18;6(3):e17876. doi: 10.1371/journal.pone.0017876.

4.

Correlated expression of Fas, NF-kappaB, and VEGF-C in infiltrating ductal carcinoma of the breast.

Dai XL, Zhou SL, Qiu J, Liu YF, Hua H.

Eur J Gynaecol Oncol. 2012;33(6):633-9.

PMID:
23327061
5.

Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.

Bandić D, Juretić A, Sarcević B, Separović V, Kujundzić-Tiljak M, Hudolin T, Spagnoli GC, Cović D, Samija M.

Croat Med J. 2006 Feb;47(1):32-41.

6.

MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis.

Yang F, Zhou X, Miao X, Zhang T, Hang X, Tie R, Liu N, Tian F, Wang F, Yuan J.

Breast Cancer Res Treat. 2014 May;145(1):23-32. doi: 10.1007/s10549-014-2915-9. Epub 2014 Apr 1.

7.

Expression of cancer-testis antigen CT7 (MAGE-C1) in breast cancer: an immunohistochemical study with emphasis on prognostic utility.

Krüger S, Ola V, Feller AC, Fischer D, Friedrich M.

Pathol Oncol Res. 2007;13(2):91-6. Epub 2007 Jul 3.

8.

P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer.

Turashvili G, McKinney SE, Goktepe O, Leung SC, Huntsman DG, Gelmon KA, Los G, Rejto PA, Aparicio SA.

Mod Pathol. 2011 Jan;24(1):64-81. doi: 10.1038/modpathol.2010.189. Epub 2010 Sep 17.

9.

Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.

Heinonen M, Bono P, Narko K, Chang SH, Lundin J, Joensuu H, Furneaux H, Hla T, Haglund C, Ristimäki A.

Cancer Res. 2005 Mar 15;65(6):2157-61.

10.

Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer.

Lin H, Huang JF, Qiu JR, Zhang HL, Tang XJ, Li H, Wang CJ, Wang ZC, Feng ZQ, Zhu J.

Exp Mol Pathol. 2013 Feb;94(1):73-8. doi: 10.1016/j.yexmp.2012.08.004. Epub 2012 Sep 29.

PMID:
23031786
11.

The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer.

Tang D, Xu S, Zhang Q, Zhao W.

Med Oncol. 2012 Jun;29(2):526-33. doi: 10.1007/s12032-011-9948-2. Epub 2011 Apr 26.

PMID:
21519872
12.

[The clinical significance of P-glycoprotein, lung resistance protein and multidrug resistance related protein expressions in infiltrating breast carcinoma tissues].

Zuo WS, Wei L, Song XR, Wang XW, Wang MY, Wang YS, Yu ZY, Bi Y.

Zhonghua Yi Xue Za Zhi. 2006 Nov 28;86(44):3142-5. Chinese.

PMID:
17313768
13.

Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.

Aziz SA, Pervez S, Khan SM, Kayani N, Nasir MI.

J Coll Physicians Surg Pak. 2005 Apr;15(4):225-9.

PMID:
15857596
14.

HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection.

Li Y, Xu J, Chen L, Zhong WD, Zhang Z, Mi L, Zhang Y, Liao CG, Bian HJ, Jiang JL, Yang XM, Li XY, Fan CM, Zhu P, Fu L, Chen ZN.

Histopathology. 2009 May;54(6):677-87. doi: 10.1111/j.1365-2559.2009.03280.x. Erratum in: Histopathology. 2009 Jun;54(7):918. Chen, Li [corrected to Chen, Ling].

PMID:
19438743
15.

Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast.

Al-Joudi FS, Iskandar ZA, Hasnan J, Rusli J, Kamal Y, Imran AK, Ahmed M, Zakaria J.

Singapore Med J. 2007 Jul;48(7):607-14.

16.

Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.

Mylonas I, Jeschke U, Shabani N, Kuhn C, Friese K, Gerber B.

Oncol Rep. 2005 Jan;13(1):81-8.

PMID:
15583806
17.

COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers.

Miglietta A, Toselli M, Ravarino N, Vencia W, Chiecchio A, Bozzo F, Motta M, Torchio B, Bocca C.

Expert Opin Ther Targets. 2010 Jul;14(7):655-64. doi: 10.1517/14728222.2010.486792.

PMID:
20536410
18.

Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.

Wang Z, Shi Q, Wang Z, Gu Y, Shen Y, Sun M, Deng M, Zhang H, Fang J, Zhang S, Xie F.

Pathol Res Pract. 2011 Aug 15;207(8):505-13. doi: 10.1016/j.prp.2011.06.009. Epub 2011 Jul 28.

PMID:
21802218
19.

[Expression of the genes FHIT, Bcl-2 and Bax in breast infiltrating ductal carcinoma and clinicopathological significance thereof].

Wang ZB, Zhao P, Liu M, Li XH.

Zhonghua Yi Xue Za Zhi. 2006 Aug 22;86(31):2171-6. Chinese.

PMID:
17064501
20.

Expression of c-met is a strong independent prognostic factor in breast carcinoma.

Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, Rimm DL.

Cancer. 1998 Apr 15;82(8):1513-20.

PMID:
9554529

Supplemental Content

Support Center